Taken together, the results above suggest that GCN5L1 could affect oxidative stress-induced renal damage under hyperglycemic conditions and targeting GCN5L1 could be an attractive therapeutic target of DKD. The gene discussed is BLOC1S1; the disease is diabetic kidney disease.